BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8125985)

  • 1. Pseudomonas exotoxin A mutants. Replacement of surface exposed residues in domain II with cysteine residues that can be modified with polyethylene glycol in a site-specific manner.
    Kuan CT; Wang QC; Pastan I
    J Biol Chem; 1994 Mar; 269(10):7610-6. PubMed ID: 8125985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas exotoxin A mutants. Replacement of surface-exposed residues in domain III with cysteine residues that can be modified with polyethylene glycol in a site-specific manner.
    Benhar I; Wang QC; FitzGerald D; Pastan I
    J Biol Chem; 1994 May; 269(18):13398-404. PubMed ID: 8175770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylene glycol-modified chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin.
    Wang QC; Pai LH; Debinski W; FitzGerald DJ; Pastan I
    Cancer Res; 1993 Oct; 53(19):4588-94. PubMed ID: 8402632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of a protease-sensitive region of Pseudomonas exotoxin prolongs its survival in the circulation of mice.
    Brinkmann U; Pai LH; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3065-9. PubMed ID: 1557414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alanine scanning mutagenesis identifies surface amino acids on domain II of Pseudomonas exotoxin required for cytotoxicity, proper folding, and secretion into periplasm.
    Kasturi S; Kihara A; FitzGerald D; Pastan I
    J Biol Chem; 1992 Nov; 267(32):23427-33. PubMed ID: 1429683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL.
    Seetharam S; Chaudhary VK; FitzGerald D; Pastan I
    J Biol Chem; 1991 Sep; 266(26):17376-81. PubMed ID: 1910044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the activity of barnase toxins in vitro and in vivo.
    Prior TI; Kunwar S; Pastan I
    Bioconjug Chem; 1996; 7(1):23-9. PubMed ID: 8741987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a potent chimeric toxin by replacement of domain III of Pseudomonas exotoxin with ricin A chain KDEL.
    Pitcher C; Roberts L; Fawell S; Zdanovsky AG; FitzGerald DJ; Lord JM
    Bioconjug Chem; 1995; 6(5):624-9. PubMed ID: 8974463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A.
    Yates SP; Merrill AR
    Biochem J; 2004 May; 379(Pt 3):563-72. PubMed ID: 14733615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of sequences in domain II of Pseudomonas exotoxin A which mediate translocation.
    Siegall CB; Ogata M; Pastan I; FitzGerald DJ
    Biochemistry; 1991 Jul; 30(29):7154-9. PubMed ID: 1906738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redirecting Pseudomonas exotoxin.
    FitzGerald D; Pastan I
    Semin Cell Biol; 1991 Feb; 2(1):31-7. PubMed ID: 1954341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domain II mutants of Pseudomonas exotoxin deficient in translocation.
    Jinno Y; Ogata M; Chaudhary VK; Willingham MC; Adhya S; FitzGerald D; Pastan I
    J Biol Chem; 1989 Sep; 264(27):15953-9. PubMed ID: 2506173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deletion within the translocation domain of Pseudomonas exotoxin A enhances translocation efficiency and cytotoxicity concomitantly.
    Taupiac MP; Bébien M; Alami M; Beaumelle B
    Mol Microbiol; 1999 Mar; 31(5):1385-93. PubMed ID: 10200959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the carboxyl-terminal amino acids important for the ADP-ribosylation activity of Pseudomonas exotoxin A.
    Chow JT; Chen MS; Wu HC; Hwang J
    J Biol Chem; 1989 Nov; 264(31):18818-23. PubMed ID: 2553721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity.
    Chaudhary VK; Jinno Y; FitzGerald D; Pastan I
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):308-12. PubMed ID: 2104981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of deletions within domain II of exotoxin A on its extracellular secretion from Pseudomonas aeruginosa.
    Voulhoux R; Taupiac MP; Czjzek M; Beaumelle B; Filloux A
    J Bacteriol; 2000 Jul; 182(14):4051-8. PubMed ID: 10869085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T-cell mediated tumor protection by Pseudomonas exotoxin fused to ovalbumin in C57BL/6 mice.
    Becerra JC; Arthur JF; Landucci GR; Forthal DN; Theuer CP
    Surgery; 2003 Apr; 133(4):404-10. PubMed ID: 12717358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of domain I of Pseudomonas exotoxin. Mutations in domain I of Pseudomonas exotoxin which reduce cell binding and animal toxicity.
    Jinno Y; Chaudhary VK; Kondo T; Adhya S; FitzGerald DJ; Pastan I
    J Biol Chem; 1988 Sep; 263(26):13203-7. PubMed ID: 2901411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A variant of exotoxin A that forms potent and specific chemically conjugated immunotoxins.
    Chaudry GJ; Fulton RJ; Draper RK
    J Biol Chem; 1993 May; 268(13):9437-41. PubMed ID: 8486636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas exotoxin A-epidermal growth factor (EGF) mutant chimeric protein as an indicator for identifying amino acid residues important in EGF-receptor interaction.
    Shiah HS; Chen TY; Chang CM; Chow JT; Kung HJ; Hwang J
    J Biol Chem; 1992 Nov; 267(33):24034-40. PubMed ID: 1429738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.